151 related articles for article (PubMed ID: 9090857)
21. Structure-Based design of [(2-Hydroxyethoxy)methyl]-6-(phenylthio)-thymine derivatives as nonnucleoside HIV-1 reverse transcriptase Inhibitors: From HEPTs to Sulfinyl-substituted HEPTs.
Hao Q; Wang S; Huang W; Zhang Y; Pannecouque C; De Clercq E; Chen F
Bioorg Chem; 2022 Sep; 126():105880. PubMed ID: 35649315
[TBL] [Abstract][Full Text] [Related]
22. Resistance to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptase.
Buckheit RW; Fliakas-Boltz V; Yeagy-Bargo S; Weislow O; Mayers DL; Boyer PL; Hughes SH; Pan BC; Chu SH; Bader JP
Virology; 1995 Jun; 210(1):186-93. PubMed ID: 7540784
[TBL] [Abstract][Full Text] [Related]
23. Diverse combinatorial design, synthesis and in vitro evaluation of new HEPT analogues as potential non-nucleoside HIV-1 reverse transcription inhibitors.
Puig-de-la-Bellacasa R; Giménez L; Pettersson S; Pascual R; Gonzalo E; Esté JA; Clotet B; Borrell JI; Teixidó J
Eur J Med Chem; 2012 Aug; 54():159-74. PubMed ID: 22652226
[TBL] [Abstract][Full Text] [Related]
24. Quantitative structure-activity relationship study on the anti-HIV-1 activity of novel 6-naphthylthio HEPT analogs.
Riahi S; Pourbasheer E; Dinarvand R; Ganjali MR; Norouzi P
Chem Biol Drug Des; 2009 Aug; 74(2):165-72. PubMed ID: 19549086
[TBL] [Abstract][Full Text] [Related]
25. Rationally designed dual inhibitors of HIV reverse transcriptase and integrase.
Wang Z; Bennett EM; Wilson DJ; Salomon C; Vince R
J Med Chem; 2007 Jul; 50(15):3416-9. PubMed ID: 17608468
[TBL] [Abstract][Full Text] [Related]
26. A new class of HIV-1-specific 6-substituted acyclouridine derivatives: synthesis and anti-HIV-1 activity of 5- or 6-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT).
Tanaka H; Baba M; Hayakawa H; Sakamaki T; Miyasaka T; Ubasawa M; Takashima H; Sekiya K; Nitta I; Shigeta S
J Med Chem; 1991 Jan; 34(1):349-57. PubMed ID: 1992136
[TBL] [Abstract][Full Text] [Related]
27. Predicting anti-HIV activity: computational approach using a novel topological descriptor.
Gupta S; Singh M; Madan AK
J Comput Aided Mol Des; 2001 Jul; 15(7):671-8. PubMed ID: 11688947
[TBL] [Abstract][Full Text] [Related]
28. Development of neural network QSPR models for Hansch substituent constants. 2. Applications in QSAR studies of HIV-1 reverse transcriptase and dihydrofolate reductase inhibitors.
Chiu TL; So SS
J Chem Inf Comput Sci; 2004; 44(1):154-60. PubMed ID: 14741022
[TBL] [Abstract][Full Text] [Related]
29. Anti-HIV activity of HEPT, TIBO, and cyclic urea derivatives: structure-property studies, focused combinatorial library generation, and hits selection using substructural molecular fragments method.
Solov'ev VP; Varnek A
J Chem Inf Comput Sci; 2003; 43(5):1703-19. PubMed ID: 14502505
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents.
Tanaka H; Takashima H; Ubasawa M; Sekiya K; Nitta I; Baba M; Shigeta S; Walker RT; De Clercq E; Miyasaka T
J Med Chem; 1992 Dec; 35(25):4713-9. PubMed ID: 1469700
[TBL] [Abstract][Full Text] [Related]
31. Development of linear and nonlinear predictive QSAR models and their external validation using molecular similarity principle for anti-HIV indolyl aryl sulfones.
Roy K; Mandal AS
J Enzyme Inhib Med Chem; 2008 Dec; 23(6):980-95. PubMed ID: 18608761
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and anti-HIV activity of 2-, 3-, and 4-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT).
Tanaka H; Baba M; Ubasawa M; Takashima H; Sekiya K; Nitta I; Shigeta S; Walker RT; De Clercq E; Miyasaka T
J Med Chem; 1991 Apr; 34(4):1394-9. PubMed ID: 2016715
[TBL] [Abstract][Full Text] [Related]
33. 3D-QSAR and docking studies on the HEPT derivatives of HIV-1 reverse transcriptase.
Latha RS; Vijayaraj R; Singam ER; Chitra K; Subramanian V
Chem Biol Drug Des; 2011 Sep; 78(3):418-26. PubMed ID: 21689378
[TBL] [Abstract][Full Text] [Related]
34. [HEPT and its related compounds as anti-HIV agents].
Miyasaka T; Tanaka H; Baba M
Nihon Rinsho; 1993 Sep; 51 Suppl():200-6. PubMed ID: 7505847
[No Abstract] [Full Text] [Related]
35. "In silico" design of potential anti-HIV actives using fragment descriptors.
Varnek A; Solov'ev VP
Comb Chem High Throughput Screen; 2005 Aug; 8(5):403-16. PubMed ID: 16101580
[TBL] [Abstract][Full Text] [Related]
36. Nonnucleoside HIV-1 reverse transcriptase inhibitors: Part I. Synthesis and structure-activity relationship of 1-alkoxymethyl-5-alkyl-6-naphthylmethyl uracils as HEPT analogues.
Meng G; Chen FE; De Clercq E; Balzarini J; Pannecouque C
Chem Pharm Bull (Tokyo); 2003 Jul; 51(7):779-89. PubMed ID: 12843582
[TBL] [Abstract][Full Text] [Related]
37. Design of novel leads: ligand based computational modeling studies on non-nucleoside reverse transcriptase inhibitors (NNRTIs) of HIV-1.
Jain Pancholi N; Gupta S; Sapre N; Sapre NS
Mol Biosyst; 2014 Feb; 10(2):313-25. PubMed ID: 24292893
[TBL] [Abstract][Full Text] [Related]
38. Dihydropyrimidinone-isatin hybrids as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Devale TL; Parikh J; Miniyar P; Sharma P; Shrivastava B; Murumkar P
Bioorg Chem; 2017 Feb; 70():256-266. PubMed ID: 28160944
[TBL] [Abstract][Full Text] [Related]
39. Nonnucleoside HIV-1 reverse-transcriptase inhibitors, part 5. Synthesis and anti-HIV-1 activity of novel 6-naphthylthio HEPT analogues.
Sun GF; Chen XX; Chen FE; Wang YP; De Clercq E; Balzarini J; Pannecouque C
Chem Pharm Bull (Tokyo); 2005 Aug; 53(8):886-92. PubMed ID: 16079514
[TBL] [Abstract][Full Text] [Related]
40. Effect of human serum on the in vitro anti-HIV-1 activity of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) derivatives as related to their lipophilicity and serum protein binding.
Baba M; Yuasa S; Niwa T; Yamamoto M; Yabuuchi S; Takashima H; Ubasawa M; Tanaka H; Miyasaka T; Walker RT
Biochem Pharmacol; 1993 Jun; 45(12):2507-12. PubMed ID: 8328988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
